Regulators Moving Ahead Of Industry In China? Officials, Execs Weigh In

Shorter INDs But Trial Delays

 
• By Brian Yang
  
DIA China 2021 meeting
REGULATORS MOVE FAST AND INDUSTRY NEEDS TO DO ITS PART, SAYS CHINA'S TOP DRUG REVIEW OFFICIAL • Source: Pink Sheet/Brian Yang
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from China

More from Asia